Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents.
Balestri LJI, D'Agostino I, Rango E, Vagaggini C, Marchitiello R, Mariotti M, Casian A, Deodato D, Truglio GI, Orofino F, Sanguinetti M, Bugli F, Botta L, Dreassi E. Balestri LJI, et al. Among authors: vagaggini c. Mol Divers. 2022 Dec;26(6):3399-3409. doi: 10.1007/s11030-022-10388-7. Epub 2022 Feb 10. Mol Divers. 2022. PMID: 35143033 Free PMC article.
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives.
Bononi G, Di Stefano M, Poli G, Ortore G, Meier P, Masetto F, Caligiuri I, Rizzolio F, Macchia M, Chicca A, Avan A, Giovannetti E, Vagaggini C, Brai A, Dreassi E, Valoti M, Minutolo F, Granchi C, Gertsch J, Tuccinardi T. Bononi G, et al. Among authors: vagaggini c. J Med Chem. 2022 May 26;65(10):7118-7140. doi: 10.1021/acs.jmedchem.1c01806. Epub 2022 May 6. J Med Chem. 2022. PMID: 35522977 Free PMC article.
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme.
Poggialini F, Vagaggini C, Brai A, Pasqualini C, Crespan E, Maga G, Perini C, Cabella N, Botta L, Musumeci F, Frosini M, Schenone S, Dreassi E. Poggialini F, et al. Among authors: vagaggini c. Pharmaceutics. 2023 Jan 30;15(2):453. doi: 10.3390/pharmaceutics15020453. Pharmaceutics. 2023. PMID: 36839775 Free PMC article.
Progress towards Adjuvant Development: Focus on Antiviral Therapy.
Brai A, Poggialini F, Pasqualini C, Trivisani CI, Vagaggini C, Dreassi E. Brai A, et al. Among authors: vagaggini c. Int J Mol Sci. 2023 May 25;24(11):9225. doi: 10.3390/ijms24119225. Int J Mol Sci. 2023. PMID: 37298177 Free PMC article. Review.
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth.
Maresca L, Crivaro E, Migliorini F, Anichini G, Giammona A, Pepe S, Poggialini F, Vagaggini C, Giannini G, Sestini S, Borgognoni L, Lapucci A, Dreassi E, Taddei M, Manetti F, Petricci E, Stecca B. Maresca L, et al. Among authors: vagaggini c. Pharmacol Res. 2023 Sep;195:106858. doi: 10.1016/j.phrs.2023.106858. Epub 2023 Jul 19. Pharmacol Res. 2023. PMID: 37473878 Free article.
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors.
Di Stefano M, Masoni S, Bononi G, Poli G, Galati S, Gado F, Manzi S, Vagaggini C, Brai A, Caligiuri I, Asif K, Rizzolio F, Macchia M, Chicca A, Sodi A, Di Bussolo V, Minutolo F, Meier P, Gertsch J, Granchi C, Dreassi E, Tuccinardi T. Di Stefano M, et al. Among authors: vagaggini c. Eur J Med Chem. 2024 Jan 5;263:115916. doi: 10.1016/j.ejmech.2023.115916. Epub 2023 Nov 2. Eur J Med Chem. 2024. PMID: 37976705 Free article.
25 results